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ABSTRACT
NSCs (neural stem cells) are undifferentiated neural cells
endowed with a high potential for proliferation and a
capacity for self-renewal with retention of multipotency to
differentiate into neurons and glial cells. It has been
recently reported that GD3, a b-series ganglioside, is a
marker molecule for identifying and isolating mouse NSCs.
However, the expression of gangliosides in human NSCs is
largely unknown. In the present study, we analysed the
expression of gangliosides, GD2 and GD3, in human NSCs
that were isolated from human brains at gestational week
17 in the form of neurospheres, which are floating clonal
aggregates formed by NSCs in vitro. Employing immuno-
cytochemistry, we found that human NSCs were strongly
reactive to anti-GD2 antibody and relatively weakly reac-
tive to anti-GD3 antibody. Treatment of these cells with an
organic solvent such as 100% methanol, which selectively
removes glycolipids from plasma membrane, abolished the
immunoreactivity with those antibodies, indicating that the
reactivity was due to GD2 and GD3, but not to GD2-/GD3-
like glycoproteins or proteoglycans. The immunoreactivity
of human NSCs to antibody against SSEA-1 (stage-specific
embryonic antigen-1), a well-known carbohydrate antigen
of NSCs, was not decreased by the treatment with 100%
methanol, indicating that SSEA-1 is mainly carried by
glycoproteins and/or proteoglycans in human NSCs. Our
study suggests that GD2 and GD3 can be marker
gangliosides for identifying human NSCs.
Key words: ganglioside, glycosphingolipid (GSL), neural
stem cell (NSC), neurosphere, stage-specific embryonic
antigen-1 (SSEA-1).
INTRODUCTION
NSCs (neural stem cells) are undifferentiated neural cells
endowed with a high potential for proliferation and a
capacity for self-renewal with retention of multipotency to
differentiate into brain-forming cells such as neurons and
glial cells (Weiss et al., 1996; McKay, 1997; Gage, 2000; Zhao
et al., 2008). For studying their basic biological properties
and clinical applications, it is important to characterize
marker molecules for identifying and isolating NSCs from
brain tissues. To date, a number of marker molecules have
been found in NSCs, e.g., nestin, Sox2, Musashi-1, SSEA-1
(stage-specific embryonic antigen-1; also known as Lewis x
antigen or CD15) and prominin-1 (CD133). To study NSCs
more systematically and thoroughly, however, it is still
essential to explore other cell-surface marker molecules of
NSCs.
GSLs (glycosphingolipids) are lipids that contain at least
one monosaccharide residue and either a sphingoid base or a
ceramide (Hakomori, 1990; Yu et al., 2007, 2009). GSLs having
at least one sialic acid residue in their carbohydrate chains
are referred to as gangliosides. GSLs, including ganglio-
sides, are ubiquitously expressed in vertebrate tissues, cells
and body fluids, and are most abundant in the nervous
system. The expression of gangliosides changes drastically
during brain development. For instance, in rodents, simple
GM3 and GD3 are predominant gangliosides in embryonic
brains, but more complex gangliosides such as GM1, GD1a,
GD1b and GT1b prevail in adult brains (Yu, 1994; Ngamukote
et al., 2007). In cells, GSLs, including gangliosides, are
localized in the outer leaflet of the plasma membrane and
their carbohydrate moieties are exposed to the extracellular
region. Thus, GSLs can be useful as stage-specific cell surface
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2007; Yu et al., 2010; Yanagisawa, 2011). For instance,
galactosylceramide (O1 antigen), sulfatide (O4 antigen) and
c-series gangliosides (A2B5 antigens) have been used as
marker molecules to identify and isolate cells of the glial
lineage (Yanagisawa and Yu, 2007). In mouse NSCs, GD3
ganglioside is such a marker molecule.
GD3 (CD60a; NeuAca2-8NeuAca2-3Galb1-4Glcb1-19Cer)
is a b-series disialoganglioside that is frequently expressed
in immature proliferative cells (Seyfried and Yu, 1985). In
rodent brains, GD3 is heavily concentrated in the subven-
tricular zone of the lateral ventricle (Goldman et al., 1984),
where adult NSCs are localized (Doetsch et al., 1999). Also,
GD3 has been reported to be expressed in mouse
neuroepithelial cells that are rich in NSCs (Yanagisawa
et al., 2004) and mouse radial glia, bipolar cells transiently
appearing in the neuroepithelium and playing roles as NSCs
at the embryonic stage (Cammer and Zhang, 1996). These
observations suggest the expression of GD3 in rodent NSCs.
In fact, we have recently provided direct evidence that GD3
is expressed in bulk-isolated mouse embryonic, postnatal
and adult NSCs (Nakatani et al., 2010). Interestingly, GD3
+
cells isolated from mouse brains by FACS have all the
characteristics of NSCs (Nakatani et al., 2010). Our study
clearly indicates the importance of GD3 as a biomarker of
mouse NSCs. On the other hand, it has been reported that
human NSCs were recognized by an antibody against GD2
[GalNAcb1-4(NeuAca2-8NeuAca2-3)Galb1-4Glcb1-19Cer],
another b-series disialoganglioside (Klassen et al., 2001).
However, the possibility that the immunoreactivity is
attributed to other glycoconjugates such as proteoglycans
and glycoproteins that have the epitopic structure of GD2
cannot be ruled out. In addition, it has not been shown
whether GD3 is also expressed in NSCs prepared from human
embryonic brain. In the present study, therefore, we
analysed the expression of gangliosides (i.e., GD2 and GD3)




NSCs isolated from human brains at gestational week 17 in
the form of neurospheres and stored in liquid nitrogen
(Poetic Normal Human Neural Progenitors; catalogue no. PT-
2599; lot no. 0000089197; Lonza Walkersville, Walkersville,
MD, U.S.A.; Tanikawa et al., 2003; Krathwohl and Kaiser,
2004; Zawlik et al., 2006) were revived and cultured in Neural
Progenitor Maintenance medium that contained human
recombinant bFGF (basic fibroblast growth factor) and
human recombinant epidermal growth factor (Lonza
Walkersville). These NSCs were collected into 1.5-ml tubes
or re-plated on to Chamber Slides (Nalge Nunc International,
Naperville, IL, U.S.A.) that were coated with 20 mg/ml Cultrex
mouse laminin I (Trevigen, Gaithersburg, MD, U.S.A.) for
immunocytochemistry.
Immunocytochemistry
Human NSCs, collected in 1.5-ml tubes or re-plated on to
Chamber Slides, were fixed in PBS that contained 4% (w/v)
paraformaldehyde. To wash out lipids that include ganglio-
sides of the plasma membranes, cells were treated with
100% methanol for 10 min. The cells were treated for 2 h
with PBS that contained 3% (v/v) FBS (fetal bovine serum)
without detergent for blocking non-specific binding of
antibodies. To stain nestin, PBS containing 3% FBS and 0.1%
Triton X-100 was used for blocking and permeabilization.
These NSCs were stained with isotype control mouse IgG (BD
Biosciences, San Jose, CA, U.S.A.), isotype control mouse IgM
(BD Biosciences), 10C2 anti-human nestin monoclonal
antibody (Millipore, Billerica, MA, U.S.A.), AK97 anti-SSEA-
1 monoclonal antibody (mouse IgM) (Yanagisawa et al.,
1999), 14G2a anti-GD2 monoclonal antibody (mouse IgG;
Millipore) (Mujoo et al., 1989) or R24 anti-GD3 monoclonal
antibody (mouse IgG) (Pukel et al., 1982) and then with anti-
mouse IgG antibody conjugated with Alexa FluorH 488
(Invitrogen, Carlsbad, CA, U.S.A.) or anti-mouse IgM
antibody conjugated with Alexa FluorH 488 (Invitrogen).
Nuclei were stained with 2 mg/ml Hoechst 33258 (Sigma–
Aldrich, St. Louis, MO, U.S.A.) in PBS. The stained cells were
Figure 1 Marker expression of human NSCs
Human NSCs, Poetic Normal Human Neural Progenitors, prepared from hu-
man brains at gestational week 17 in the form of neurospheres (A) were
immunostained with anti-human nestin antibody (mouse IgG) and anti-
SSEA-1 antibody (mouse IgM) (B). Human NSCs were positive for nestin
(green) and SSEA-1 (green), marker molecules of NSCs. coIgG and coIgM
indicate human NSCs stained with isotype control mouse IgG and IgM
respectively. Nuclei were stained with Hoechst 33258 (blue).
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Hatfield, PA, U.S.A.), covered with a coverslip and then
photographed under a Nikon Eclipse TE300 fluorescent
microscope (Nikon Instruments, Melville, NY, U.S.A.)
equipped with a Magnafire digital charge-coupled device
camera (Optronics, Goleta, CA, U.S.A.).
Mouse NSC culture
Mouse NSCs were preparedfrom brainsof ICR mice(embryonic
day 14.5; Harlan, Indianapolis, IN, U.S.A.) in the form of
neurospheres as previously described (Reynolds et al., 1992;
Nakatani et al., 2010; Yagi et al., 2010b). Neurospheres formed
in Neurobasal A medium (Invitrogen) that contained B27 sup-
plement (Invitrogen), 2 mM L-glutamine (Invitrogen), 20 ng/ml
human recombinant bFGF (Peprotech, Rocky Hill, NJ, U.S.A.)
and 20 ng/ml human recombinant epidermal growth factor
(Peprotech) were collected into 1.5-ml tubes or plated on to
Chamber Slides that were coated with poly-L-ornithine
(Sigma–Aldrich) and bovine fibronectin (Sigma–Aldrich).
These mouse NSCs in 1.5-ml tubes or on Chamber Slides were
fixed and immunostained as described above. Mice used in this
study were treated according to the guidelines of the
Institutional Animal Care and Use Committee of Georgia
Health Sciences University.
RESULTS
In the present study, we analysed commercially available
human NSCs, Poetic Normal Human Neural Progenitors
(Tanikawa et al., 2003; Krathwohl and Kaiser, 2004; Zawlik
et al., 2006), prepared from human brains at gestational week
17 in the form of neurospheres, which are floating clonal
aggregates formed by NSCs in vitro (Figure 1A). These human
NSCs were confirmed to be positive for marker molecules of
Figure 2 Effect of methanol on GD2, SSEA-1 and GD3 immunoreactivity in human NSCs
Human NSCs treated with or without methanol (MeOH) were immunostained with antibodies against GD2 (A), SSEA-1 (B) and GD3 (C).
Human NSCs were positive for GD2 (green; A) and relatively weakly positive for GD3 (green; C). No immunoreactivity of human NSCs to
antibodies against GD2 (A) and GD3 (C) after treatment with 100% methanol for 10 min to wash out lipids of plasma membranes
indicates that the immunoreactivity is attributed to GD2 and GD3 gangliosides, but not to glycoproteins or proteoglycans. (B) Human
NSCs treated with methanol were still positive for SSEA-1 (green), indicating that SSEA-1 is mainly carried by glycoproteins and/or
proteoglycans in these cells. (D) Mouse embryonic NSCs prepared from mouse brains at embryonic day 14 in the form of neurospheres
were stained with anti-GD3 antibody (green) as a positive control. Nuclei were stained with Hoechst 33258 (blue).
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71NSCs, nestin and SSEA-1, as Klassen et al., (2001) have
previously reported (Figure 1B).
First, we immunostained these human NSCs with antibody
against a b-series ganglioside, GD2. As shown in Figure 2(A),
human NSCs were immunoreactive with anti-GD2 antibody as
Klassen et al. (2001) have previously reported. However, there
wasapossibilitythattheanti-GD2antibodycross-reactedwith
glycoproteins or proteoglycans that have carbohydrate
structures similar to those of GD2 in human NSCs. It is well
known that lipids, including glycolipids in the plasma mem-
brane, are easily washed out by treatment of the cells with an
organic solvent before immunocytochemistry (Kinoshita et al.,
2009). To confirm that the immunoreactivity of human NSCs
with anti-GD2 antibody was attributed to GD2, we treated
these cells with 100% methanol for 10 min to wash out plas-
ma membrane lipids, including gangliosides. As shown in
Figure 2(A), human NSCs thus treated lost completely their
immunoreactivity to anti-GD2 antibody. This result indicates
that the immunoreactivity against anti-GD2 antibody was
attributed to GD2, but not to glycoproteins or proteoglycans
having the same epitopic structure of GD2. In contrast, the
immunoreactivity of human NSCs to anti-SSEA-1 antibody
was resistant to the treatment with 100% methanol
(Figure 2B). This clearly indicates that the SSEA-1 epitope in
human NSCs is mainly carried by glycoproteins and/or
proteoglycans, but not by glycolipid antigens. As shown in
Figure 2(C), human NSCs were also reactive with an antibody
against GD3, a predominant ganglioside in mouse NSCs
(Nakatani et al., 2010) (Figure 2D). The immunoreactivity of
human NSCs to anti-GD3 antibody was relatively weaker than
that to anti-GD2 antibody (results not shown). The sensitivity
of the GD3 immunoreactivity to methanol treatment
(Figure 2C) indicates that GD3, but not glycoproteins or
proteoglycans having carbohydrate structures of GD3, is
expressed in human NSCs.
From mouse NSCs and neural precursor cells, certain
gangliosides other than GD3 such as GT1b, GQ1b, GT1aa
[originally designated GTx (Nakamura et al., 1988); Chol-1a
antigen] and GQ1ba (Chol-1a antigen) have been identified
so far (Yanagisawa et al., 2004; Ngamukote et al., 2007;
Nakatani et al., 2010; Yanagisawa, 2011). GD2, however, has
not been biochemically detected in mouse NSCs. Then, we
evaluated whether mouse NSCs express GD2 ganglioside as
human NSCs. As shown in Figure 3, mouse NSCs were posi-
tive for not only GD3 but also GD2. As previously reported
(Yanagisawa et al., 2005), the GD3 immunoreactivity disap-
peared in mouse NSCs treated with methanol (Figure 3).
Similarly, the GD2 immunoreactivity disappeared in mouse
NSCs treated with methanol (Figure 3), suggesting that GD2
immunoreactivity in mouse NSCs is also attributed to GD2,
but not to glycoproteins or proteoglycans having the same
epitopic structures of GD2. There have been results suggest-
ing that the expression of GD2 in mouse NSCs is less than the
amount required for chemical detection based on TLC
(Nakatani et al., 2010). The finding in the previous study
and the result in the present study establish that GD2 is
unequivocally expressed in mouse NSCs, albeit at a lower
concentration.
DISCUSSION
In the present study, we analysed the expression of gang-
liosides in human NSCs. As Klassen et al. (2001) have
previously reported, human NSCs were reactive with antibody
against GD2. In addition, these human NSCs were relatively
weakly reactive with antibody against GD3, a predominant
ganglioside in mouse NSCs (Nakatani et al., 2010). No
immunoreactivity of the human NSCs to antibodies against
GD2 and GD3 after treatment with methanol to wash out
lipids of plasma membranes confirmed that GD2 and GD3
gangliosides were expressed in human NSCs.
SSEA-1, which is expressed in mouse NSCs (Klassen et al.,
2001; Capela and Temple, 2002), was also found in human NSCs.
The carbohydrate determinant of this antigen [Galb1-4
(Fuca1-3)GlcNAcb1-] is usually carried by proteoglycans,
Figure 3 Effect of methanol on GD2 and GD3 immunoreactivity in mouse
embryonic NSCs
Mouse embryonic NSCs were stained with anti-GD3 antibody (green) and
anti-GD2 antibody (green). No immunoreactivity to antibodies against GD2
and GD3 in cells treated with 100% methanol (MeOH) for 10 min indicates
that the GD3 and GD2 immunoreactivity is attributed to GD3 and GD2
gangliosides, but not to glycoproteins or proteoglycans. Nuclei were stained
with Hoechst 33258 (blue).
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of this epitope in human NSCs, however, has not been fully
characterized. The immunoreactivity of SSEA-1 in human NSCs
wasresistant tothe methanol treatment, suggestingthat SSEA-1
is mainly carried by glycoproteins and/or proteoglycans, but not
by glycolipids. This result is consistent with the analysis of SSEA-
1 in mouse neuroepithelial cells (Yanagisawa et al., 2005).
Recently, LAMP-1 (lysosome-associated membrane protein-1)
was identified as a major SSEA-1 carrier protein in mouse NSCs
(Yagi et al., 2010a). There is a possibility that LAMP-1 is also a
major SSEA-1 carrier protein in human NSCs.
Recently, we have reported that GD3 can be a marker
molecule for isolating NSCs from mouse embryonic, postnatal
and adult brains (Nakatani et al., 2010). Also, some researchers
have found that GD2 is useful as a marker molecule for
isolating mesenchymal stem cells, multipotent stromal cells
that can differentiate into cells of the mesodermal lineage
such as myocytes, osteocytes, adipocytes and chondrocytes,
from humanbone marrow(Martinezet al., 2007) and umbilical
cord blood (Xu et al., 2009; Jin et al., 2010). Similar to these, it
is anticipated that GD2 and GD3 confirmed to be expressed in
human NSCs in the present study also can be marker molecules
available for identifying and isolating NSCs in human brains
especially in adulthood; in adult human brains, GM1, GD1a,
GD1b and GT1b, but not GD2 and GD3, are predominantly
expressed (Svennerholm, 1963). Further systematic studies of
gangliosides in human NSCs should be important for the
progress of stem cell biology.
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